Cart
sales@molnova.com
Thymidylate Kinase Inhibitor, YMU1
CAS No. 902589-96-2
Thymidylate Kinase Inhibitor, YMU1( —— )
Catalog No. M24937 CAS No. 902589-96-2
YMU1 is a human thymidylate kinase (hTMPK) inhibitor. YMU1 stabilizes the conformation of ligand-induced degradation (LID) region of hTMPK and blocks the catalytic site or ATP-binding site.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 41 | In Stock |
|
| 10MG | 65 | In Stock |
|
| 25MG | 130 | In Stock |
|
| 50MG | 205 | In Stock |
|
| 100MG | 330 | In Stock |
|
| 200MG | 460 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameThymidylate Kinase Inhibitor, YMU1
-
NoteResearch use only, not for human use.
-
Brief DescriptionYMU1 is a human thymidylate kinase (hTMPK) inhibitor. YMU1 stabilizes the conformation of ligand-induced degradation (LID) region of hTMPK and blocks the catalytic site or ATP-binding site.
-
DescriptionYMU1 is a human thymidylate kinase (hTMPK) inhibitor. YMU1 stabilizes the conformation of ligand-induced degradation (LID) region of hTMPK and blocks the catalytic site or ATP-binding site.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorhTMPK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number902589-96-2
-
Formula Weight378.45
-
Molecular FormulaC17H22N4O4S
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESCCOC(=O)N1CCN(CC1)C(=O)CN2C(=O)C3=C(S2)N=C(C=C3C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Dong B , Jaeger A M , Hughes P F , et al. Targeting therapy-resistant prostate cancer via a direct inhibitor of the human heat shock transcription factor 1[J]. Science Translational Medicine, 2020, 12(574):eabb5647.
molnova catalog
related products
-
prifinium bromide
Prifinium bromide is a quaternary ammon antimuscarinic. It inhibits hyperkinesia of the digestive organs and urinary tract and has a spasmolytic action.
-
Manzamine A
Manzamine A, an orally active beta-carboline alkaloid, inhibits specifically GSK-3β and CDK-5 with IC50s of 10.2 μM and 1.5 μM, respectively. Manzamine A targets vacuolar ATPases and inhibits autophagy in pancreatic cancer cells. Manzamine A has antimalarial and anticancer activities. Manzamine A also shows potent activity against HSV-1.
-
Oxynitidine
Oxynitidine is an HBV inhibitor (ID50=30.8 μg/mL), which can effectively inhibit the DNA replication activity of HBV. Oxynitidine can be used in the study of viral infections.
